{"id":"https://genegraph.clinicalgenome.org/r/719080af-e84b-4508-a0c2-bd4b4aa5789bv1.1","type":"EvidenceStrengthAssertion","dc:description":"ATP2B2 was first reported in relation to autosomal dominant nonsyndromic hearing loss in 2018 (Smits et al., PMID: 30535804). This condition is characterized by early-onset/congenital hearing loss, which ranges in severity and is often progressive. 8 variants (nonsense, frameshift, splicing), many of which were de novo, that have been reported in at least 26 probands in 4 publications (PMIDs: 30535804, 33105617, 33111345, 36194208) are included in this curation. The maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (2 mouse models and functional alteration evidence; PMIDs: 9668038, 20826782). Mutant mouse models show significant hearing loss in both homozygous and heterozygous mutants. Other features seen in the mutants include lack of otoconia, structural ear anomalies, and impaired calcium homeostasis. Functional alteration evidence in Chinese Hamster Ovary cells shows impaired calcium homeostasis in the mutants. In summary, there is definitive evidence supporting the relationship between ATP2B2 and autosomal dominant nonsyndromic hearing loss. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss GCEP on the meeting date 06/18/2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/719080af-e84b-4508-a0c2-bd4b4aa5789b","GCISnapshot":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2025-07-22T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2025-07-22T20:54:43.385Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2fe4126-971f-43bb-924d-9715a4bcb3c7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c12cb4a4-3fb2-457a-938e-c07141277291","type":"FunctionalAlteration","dc:description":"Calcium homeostasis was altered in the mutant. This is linked to hearing loss due to ATP2B2 mutation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20826782","rdfs:label":"Chinese Hamster Ovary Cell Analysis "}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a895d1e3-088a-43d4-b9cd-46f01be18160","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67837d12-c32e-4625-a306-37020edd26e3","type":"Finding","dc:description":"Hearing impairment in both the homozygous and heterozygous mutant mice is consistent with the hearing loss seen in affected humans. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9668038","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/30ae2474-f07c-40da-90ea-85f827fc7ffd","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dffa0fe-e32a-4518-80a7-aa1d4b4dbc82","type":"Finding","dc:description":"Both the heterozygous and homozygous mutant mice, as well as affected humans, have hearing impairment.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20826782","rdfs:label":"Mouse model #2","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bff988a-ee62-453b-a2f7-e9fa3cf192d5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bff988a-ee62-453b-a2f7-e9fa3cf192d5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30535804","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3ae8b37-6302-42b3-9a95-611df0376fdb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.1963G>T (p.Glu655Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351780741"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5ff0d42c-942a-4fdb-b935-abb293047aa3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ff0d42c-942a-4fdb-b935-abb293047aa3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30535804","allele":{"id":"https://genegraph.clinicalgenome.org/r/167747d4-ed8e-49b0-ab3e-5eb16a0d81e2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.2329C>T (p.Arg777Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351779530"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3e26e6a1-7542-484e-82db-a6399a352a0d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e26e6a1-7542-484e-82db-a6399a352a0d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30535804","allele":{"id":"https://genegraph.clinicalgenome.org/r/0cf9bbca-4f14-4842-b519-f9aebb4f99ab","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.955del (p.Ala319GlnfsTer13)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573136160"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c7ef586d-679e-4035-b8e8-c06bba621f1f","type":"EvidenceLine","dc:description":"Downgraded as the variant is associated with in-frame skipping of exon 2, removing < 10 % (5.3 %) of protein ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7ef586d-679e-4035-b8e8-c06bba621f1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30535804","allele":{"id":"https://genegraph.clinicalgenome.org/r/41784400-ba87-4596-872e-2e84eaeed627","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.397+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351777737"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/58448c50-2610-46b2-8227-35751dce10f2","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58448c50-2610-46b2-8227-35751dce10f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33111345","allele":{"id":"https://genegraph.clinicalgenome.org/r/283569ac-4257-456a-8826-b5207edbd9cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.1033C>T (p.Gln345Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351785480"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/93cd1806-dc7a-457b-b472-f26e815e3023","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93cd1806-dc7a-457b-b472-f26e815e3023_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30535804","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d5469be-a6c0-405c-9da7-0e8eb8d092ee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.1998C>A (p.Cys666Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351780600"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7cdd5b43-b57b-495d-be30-96a35b3f6e6a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cdd5b43-b57b-495d-be30-96a35b3f6e6a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33105617","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa44c7a1-8c19-448f-9cc0-191bc713d5a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.962C>G (p.Ser321Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351785969"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7e444a4f-bb41-4ec6-b7f4-14dd9c64488d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e444a4f-bb41-4ec6-b7f4-14dd9c64488d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36194208","allele":{"id":"https://genegraph.clinicalgenome.org/r/10d769d1-6b66-4e7a-af1f-97436423c710","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001001331.4(ATP2B2):c.2155A>T (p.Lys719Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351780004"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96892fcd-59f3-452d-96f6-9f02b4f4c5fe_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33105617","rdfs:label":"Family 28, 6 affecteds with variant ","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/96892fcd-59f3-452d-96f6-9f02b4f4c5fe","type":"Family","rdfs:label":"Family 28, 6 affecteds with variant ","member":{"id":"https://genegraph.clinicalgenome.org/r/1c5d54f2-cf3b-4a60-b6e5-b6aff79ed106","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33105617","rdfs:label":"p.Ser321Ter, from family 28 ","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa44c7a1-8c19-448f-9cc0-191bc713d5a0"},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0000365","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7cdd5b43-b57b-495d-be30-96a35b3f6e6a_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"phenotypes":"obo:HP_0000365","proband":{"id":"https://genegraph.clinicalgenome.org/r/1c5d54f2-cf3b-4a60-b6e5-b6aff79ed106"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/4e4939d0-23c9-46cd-b12d-87149550718c_proband_segregation","type":"FamilyCosegregation","dc:description":"425-gene hearing loss panel sequenced ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33111345","rdfs:label":"DF328, 8 affecteds with mutation","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/4e4939d0-23c9-46cd-b12d-87149550718c","type":"Family","rdfs:label":"DF328, 8 affecteds with mutation","member":{"id":"https://genegraph.clinicalgenome.org/r/40e16a7e-fbf4-4d3d-a5a2-eb2267599d42","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33111345","rdfs:label":"p.Gln345Ter, from DF238","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/283569ac-4257-456a-8826-b5207edbd9cb"},"detectionMethod":"425-gene hearing loss panel sequenced ","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"moderate-to-profound congenital-onset hearing loss (high-tone)\n","phenotypes":"obo:HP_0000365","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/58448c50-2610-46b2-8227-35751dce10f2_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"moderate-to-profound congenital-onset hearing loss (high-tone)\n","phenotypePositiveAllelePositive":8,"phenotypes":"obo:HP_0000365","proband":{"id":"https://genegraph.clinicalgenome.org/r/40e16a7e-fbf4-4d3d-a5a2-eb2267599d42"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/5ef92e42-7638-4989-91c0-1eddc8af9dc5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30535804","rdfs:label":"W17-0883, 4 affected family members","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/5ef92e42-7638-4989-91c0-1eddc8af9dc5","type":"Family","rdfs:label":"W17-0883, 4 affected family members","member":{"id":"https://genegraph.clinicalgenome.org/r/b09ec21c-85fe-4132-bbc2-624cf96dab15","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30535804","rdfs:label":"W17-0883","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8d5469be-a6c0-405c-9da7-0e8eb8d092ee"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"rapidly progressive hearing impairment; PTA (pure tone average) was 33 & 40 dB in the right & left ears; maximum SRS (speech recognition score) was 82 % & 74 % in right & left ears","phenotypes":"obo:HP_0001730","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/93cd1806-dc7a-457b-b472-f26e815e3023_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"rapidly progressive hearing impairment, onset onset at ages 2-5, 4, & 6 yrs.; PTA (pure tone average) ranged from 17-103 dB in probands tested; maximum SRS (speech recognition score) was 82 % & 74 % in right and left ears of one proband, and 100 % bilaterally for that proband's affected sibling (the other two probands did not have SRS data available)","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0001730","proband":{"id":"https://genegraph.clinicalgenome.org/r/b09ec21c-85fe-4132-bbc2-624cf96dab15"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":10853,"specifiedBy":"GeneValidityCriteria11","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/cE1e_mB6Qoo","type":"GeneValidityProposition","disease":"obo:MONDO_0019587","gene":"hgnc:815","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_193d07d0-5e1a-4ea1-84d6-377eb8fb5e7f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}